Apimeds Pharmaceuticals US APUS
NYSE APUS
$3.20 -0.21 (-6.14%)
As of: Oct 21, 2026 · 3:59 PM EDT

Apimeds Pharmaceuticals US (APUS) Long-Term Debt Issuances (2024 - 2025)

Updated

Apimeds Pharmaceuticals US (APUS) reported Long-Term Debt Issuances of $9.75 million for Q4 2025.

Analysis

Apimeds Pharmaceuticals US (APUS) Long-Term Debt Issuances (2024 - 2025) Analysis & Trends

For FY2025, Apimeds Pharmaceuticals US posted Long-Term Debt Issuances of $10 million.

  • By year, Long-Term Debt Issuances came in at $250,000 in FY2024.
  • Per Business Quant data, the three quarters before Q4 2025 came in at -$323,319 (Q3 2025), $323,319 (Q2 2025) and $250,000 (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 8.94 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 1.98 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Apimeds Pharmaceuticals US 5.44 Mn -14.20 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 10.01 Mn
Sep 30, 2025 -305,919.00
Jun 30, 2025 306,119.00
Mar 31, 2025 267,200.00
Dec 31, 2024 76,500.00
Sep 30, 2024 150,000.00
API Access

Apimeds Pharmaceuticals US Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=APUS&period=max&api_key=YOUR_API_KEY